2 min read
Meet Veristat at the ASCO Annual Meeting
May 29 - June 2, 2026 | Chicago, IL
▶️ At the Forefront of Oncology Progress
Veristat is pleased to attend the ASCO...
|
Veristat, a full-service CRO, can guide you through the planning and development process to help you successfully bring a new
myeloma cancer treatment to market. With 41% of our work in oncology trials and extensive experience with myeloma, Veristat can help advance your compound through the submission process. Our teams will collaborate to build the optimal program based upon the science of your product, while providing key functional services, including trial design, clinical monitoring, data management, medical writing and statistical consultation with regulatory representation.
|
|
Contact our team to learn more about our oncology experience, the work we have performed in the area of myeloma and how we can help you.
|
|
WORKING TOGETHER. The Veristat Oncology team:
Through application of cutting-edge research, novel trial designs, and innovative approaches, Veristat delivers excellence throughout every aspect of an oncology trial. |
2 min read
May 5, 2026 Veristat Events
May 29 - June 2, 2026 | Chicago, IL
Veristat is pleased to attend the ASCO...
1 min read
Apr 30, 2026 Veristat Events
May 12-13, 2026 – New Brunswick, NJ
Veristat is pleased to...